VYNE (VYNE) legal chief has 4,007 shares withheld to cover RSU taxes

Rhea-AI Filing Summary

VYNE Therapeutics Inc. chief legal officer Harsch Mutya reported a tax-related share disposition. On the vesting of restricted stock units, 4,007 shares of common stock were withheld by the company at $0.5975 per share to satisfy tax withholding requirements.

After this withholding, Mutya directly holds 121,898 shares of VYNE common stock. The transaction is classified as a tax-withholding disposition rather than an open-market sale.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Harsch Mutya

Role CHIEF LEGAL OFFICER AND GC

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	4,007	$0.5975	$2K

Holdings After Transaction: Common Stock — 121,898 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

Shares withheld for taxes: 4,007 shares Withholding price: $0.5975 per share Shares held after transaction: 121,898 shares

3 metrics

Shares withheld for taxes 4,007 shares Tax-withholding disposition on RSU vesting, code F

Withholding price $0.5975 per share Value used for shares withheld to satisfy tax requirements

Shares held after transaction 121,898 shares Direct common stock ownership after tax withholding

Key Terms

restricted stock units, tax withholding requirements, tax-withholding disposition

3 terms

restricted stock units financial

"in connection with the vesting of restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding requirements financial

"withheld by the Issuer to satisfy tax withholding requirements"

tax-withholding disposition financial

"transaction_action: "tax-withholding disposition""

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Harsch Mutya

(Last) (First) (Middle)

C/O VYNE THERAPEUTICS INC.

P.O. BOX 125

(Street)

STEWARTSVILLE NEW JERSEY 08886

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
VYNE Therapeutics Inc. [ VYNE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF LEGAL OFFICER AND GC

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/31/2026		F(1)		4,007	D	$0.5975	121,898	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.

	/s/ Mutya Harsch	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did VYNE (VYNE) report for Harsch Mutya?

VYNE reported that chief legal officer Harsch Mutya had 4,007 common shares withheld to cover taxes on vesting restricted stock units. This Form 4 transaction is a tax-withholding disposition, not an open-market purchase or sale, and adjusts his net share holdings.

How many VYNE (VYNE) shares were withheld for taxes in this Form 4?

The filing shows 4,007 VYNE common shares were withheld at $0.5975 per share to satisfy tax obligations tied to vesting restricted stock units. These shares were delivered back to the issuer rather than sold on the market, reducing the insider’s gross position.

What is Harsch Mutya’s VYNE shareholding after this tax-withholding event?

After the tax-withholding disposition, Harsch Mutya directly holds 121,898 VYNE common shares. This figure reflects his position following the 4,007 shares withheld by the issuer to satisfy tax requirements arising from restricted stock unit vesting reported in the Form 4.

Was the VYNE (VYNE) insider transaction an open-market sale or purchase?

The transaction was not an open-market sale or purchase. It is coded “F” on Form 4, meaning shares were withheld by the issuer to pay tax liabilities on equity compensation, specifically vesting restricted stock units, rather than traded on the open market.

What does code “F” mean in the VYNE (VYNE) Form 4 filing?

Code “F” indicates payment of an exercise price or tax liability by delivering securities. In this VYNE Form 4, 4,007 shares of common stock were withheld by the company to cover tax withholding requirements tied to restricted stock unit vesting for the reporting officer.